Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy

• Lucia Martiniova,

  Affiliations Reproductive and Adult Endocrinology Program, Eunice Kennedy Shriver, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia

  ⨯
• Jie Lu,

  Affiliation Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jeffrey Chiang,

  Affiliation Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Marcelino Bernardo,

  Affiliations Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Laboratory Animal Sciences Program, SAIC-Frederick, NCI-Frederick, Frederick, Maryland, United States of America

  ⨯
• Russell Lonser,

  Affiliation Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Zhengping Zhuang ,

  * E-mail: karel@mail.nih.gov (KP); zhuangp@ninds.nih.gov (ZZ)

  Affiliation Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Karel Pacak

  * E-mail: karel@mail.nih.gov (KP); zhuangp@ninds.nih.gov (ZZ)

  Affiliation Reproductive and Adult Endocrinology Program, Eunice Kennedy Shriver, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯